Identification of tumor antigens and immune subtypes in breast cancer for mRNA vaccine development

BACKGROUND: Poor prognosis, resistance to chemotherapy, insensitivity to radiotherapy, and a high prevalence of adverse drug reactions remain urgent issues for breast cancer (BC) patients. Increased knowledge of tumor immunobiology and vaccine development suggests the possibility of cancer vaccinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ruo Qi, Wang, Wei, Yan, Lei, Song, Li Ying, Guan, Xin, Zhang, Wei, Lian, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548593/
https://www.ncbi.nlm.nih.gov/pubmed/36226063
http://dx.doi.org/10.3389/fonc.2022.973712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548593/
https://www.ncbi.nlm.nih.gov/pubmed/36226063
http://dx.doi.org/10.3389/fonc.2022.973712

Ejemplares similares